NEEDHAM, Mass. – August 17, 2022 – Invicro LLC (Invicro), a global, industry-leading imaging CRO, and a subsidiary of REALM IDx, Inc., today announced the publication of the paper “Widespread cell stress and mitochondrial dysfunction in early Alzheimer’s Disease1” in Science Translational Medicine.
The study provides novel in vivo evidence for widespread, clinically relevant cellular stress and bioenergetic abnormalities in patients with early-stage Alzheimer’s Disease (AD) and highlights the potential value of mitochondrial imaging in longitudinal studies of AD.